ID   IFNL4_HUMAN             Reviewed;         179 AA.
AC   K9M1U5; K9M1A5; K9M269; K9M2P7;
DT   01-MAY-2013, integrated into UniProtKB/Swiss-Prot.
DT   06-MAR-2013, sequence version 1.
DT   18-JUN-2025, entry version 52.
DE   RecName: Full=Interferon lambda-4;
DE            Short=IFN-lambda-4;
DE   Flags: Precursor;
GN   Name=IFNL4;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1; 2; 3 AND 4), FUNCTION,
RP   POLYMORPHISM, INDUCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=23291588; DOI=10.1038/ng.2521;
RA   Prokunina-Olsson L., Muchmore B., Tang W., Pfeiffer R.M., Park H.,
RA   Dickensheets H., Hergott D., Porter-Gill P., Mumy A., Kohaar I., Chen S.,
RA   Brand N., Tarway M., Liu L., Sheikh F., Astemborski J., Bonkovsky H.L.,
RA   Edlin B.R., Howell C.D., Morgan T.R., Thomas D.L., Rehermann B.,
RA   Donnelly R.P., O'Brien T.R.;
RT   "A variant upstream of IFNL3 (IL28B) creating a new interferon gene IFNL4
RT   is associated with impaired clearance of hepatitis C virus.";
RL   Nat. Genet. 45:164-171(2013).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15057824; DOI=10.1038/nature02399;
RA   Grimwood J., Gordon L.A., Olsen A.S., Terry A., Schmutz J., Lamerdin J.E.,
RA   Hellsten U., Goodstein D., Couronne O., Tran-Gyamfi M., Aerts A.,
RA   Altherr M., Ashworth L., Bajorek E., Black S., Branscomb E., Caenepeel S.,
RA   Carrano A.V., Caoile C., Chan Y.M., Christensen M., Cleland C.A.,
RA   Copeland A., Dalin E., Dehal P., Denys M., Detter J.C., Escobar J.,
RA   Flowers D., Fotopulos D., Garcia C., Georgescu A.M., Glavina T., Gomez M.,
RA   Gonzales E., Groza M., Hammon N., Hawkins T., Haydu L., Ho I., Huang W.,
RA   Israni S., Jett J., Kadner K., Kimball H., Kobayashi A., Larionov V.,
RA   Leem S.-H., Lopez F., Lou Y., Lowry S., Malfatti S., Martinez D.,
RA   McCready P.M., Medina C., Morgan J., Nelson K., Nolan M., Ovcharenko I.,
RA   Pitluck S., Pollard M., Popkie A.P., Predki P., Quan G., Ramirez L.,
RA   Rash S., Retterer J., Rodriguez A., Rogers S., Salamov A., Salazar A.,
RA   She X., Smith D., Slezak T., Solovyev V., Thayer N., Tice H., Tsai M.,
RA   Ustaszewska A., Vo N., Wagner M., Wheeler J., Wu K., Xie G., Yang J.,
RA   Dubchak I., Furey T.S., DeJong P., Dickson M., Gordon D., Eichler E.E.,
RA   Pennacchio L.A., Richardson P., Stubbs L., Rokhsar D.S., Myers R.M.,
RA   Rubin E.M., Lucas S.M.;
RT   "The DNA sequence and biology of human chromosome 19.";
RL   Nature 428:529-535(2004).
CC   -!- FUNCTION: Cytokine that may trigger an antiviral response activating
CC       the JAK-STAT pathway and up-regulating specifically some interferon-
CC       stimulated genes. {ECO:0000269|PubMed:23291588}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:23291588}. Secreted
CC       {ECO:0000269|PubMed:23291588}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC         Comment=Additional isoforms seem to exist. However, they may be
CC         produced at very low levels due to a premature stop codon in the
CC         mRNA, leading to nonsense-mediated mRNA decay.;
CC       Name=1; Synonyms=IFNL4, p179;
CC         IsoId=K9M1U5-1; Sequence=Displayed;
CC       Name=2; Synonyms=p170;
CC         IsoId=K9M1U5-2; Sequence=VSP_046394;
CC       Name=3; Synonyms=p131;
CC         IsoId=K9M1U5-3; Sequence=VSP_046393;
CC       Name=4; Synonyms=p107;
CC         IsoId=K9M1U5-4; Sequence=VSP_046392;
CC   -!- INDUCTION: Up-regulated by polyinosinic:polycytidylic acid (polyI:C)
CC       which mimics the double-stranded hepatitis C virus.
CC       {ECO:0000269|PubMed:23291588}.
CC   -!- POLYMORPHISM: A one-base insertion, introducing a frameshift at
CC       position 22, results in inactivation of the gene in a majority of the
CC       population. That polymorphism is a good marker for predicting
CC       spontaneous hepatitis C virus (HCV) clearance and the response to
CC       treatment of chronic hepatitis C. The allele producing a functional
CC       protein able to induce an antiviral response and to prevent HCV
CC       replication in cell cultures, is less frequent in human populations and
CC       is associated with impaired spontaneous clearance of HCV.
CC       {ECO:0000269|PubMed:23291588}.
CC   -!- MISCELLANEOUS: [Isoform 1]: Active form which is able to induce an
CC       antiviral response and prevent hepatitis C virus (HCV) replication in
CC       cell cultures.
CC   -!- MISCELLANEOUS: [Isoform 2]: Inactive form. {ECO:0000305}.
CC   -!- MISCELLANEOUS: [Isoform 3]: Inactive form unable to elicit an antiviral
CC       response. {ECO:0000305}.
CC   -!- MISCELLANEOUS: [Isoform 4]: Inactive form unable to elicit an antiviral
CC       response. {ECO:0000305}.
CC   -!- SIMILARITY: Belongs to the lambda interferon family. {ECO:0000305}.
CC   -!- CAUTION: The reference genome assembly, GRCh37, describes the non-
CC       functional copy of that gene, frameshifted at position 22, that is more
CC       frequent in human populations. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; JN806225; AFQ38550.1; -; mRNA.
DR   EMBL; JN806226; AFQ38551.1; -; mRNA.
DR   EMBL; JN806233; AFQ38558.1; -; mRNA.
DR   EMBL; JN806234; AFQ38559.1; -; mRNA.
DR   EMBL; AC011445; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   RefSeq; NP_001263183.2; NM_001276254.2. [K9M1U5-1]
DR   PDB; 9BPU; EM; 3.26 A; C=21-179.
DR   PDBsum; 9BPU; -.
DR   AlphaFoldDB; K9M1U5; -.
DR   EMDB; EMD-44790; -.
DR   SMR; K9M1U5; -.
DR   ComplexPortal; CPX-6014; Interferon lambda receptor-ligand complex, IFNL4 variant.
DR   FunCoup; K9M1U5; 17.
DR   BioMuta; IFNL4; -.
DR   MassIVE; K9M1U5; -.
DR   ABCD; K9M1U5; 2 sequenced antibodies.
DR   DNASU; 101180976; -.
DR   Ensembl; ENST00000710320.1; ENSP00000518200.1; ENSG00000292250.1. [K9M1U5-3]
DR   Ensembl; ENST00000710321.1; ENSP00000518201.1; ENSG00000292250.1. [K9M1U5-1]
DR   Ensembl; ENST00000710322.1; ENSP00000518202.1; ENSG00000292250.1. [K9M1U5-4]
DR   GeneID; 101180976; -.
DR   KEGG; hsa:101180976; -.
DR   MANE-Select; ENST00000710321.1; ENSP00000518201.1; NM_001276254.2; NP_001263183.2.
DR   AGR; HGNC:44480; -.
DR   CTD; 101180976; -.
DR   DisGeNET; 101180976; -.
DR   GeneCards; IFNL4; -.
DR   HGNC; HGNC:44480; IFNL4.
DR   MIM; 615090; gene.
DR   InParanoid; K9M1U5; -.
DR   PAN-GO; K9M1U5; 4 GO annotations based on evolutionary models.
DR   BioGRID-ORCS; 101180976; 12 hits in 188 CRISPR screens.
DR   Pharos; K9M1U5; Tbio.
DR   PRO; PR:K9M1U5; -.
DR   Proteomes; UP000005640; Unplaced.
DR   RNAct; K9M1U5; protein.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005615; C:extracellular space; IDA:UniProtKB.
DR   GO; GO:0005125; F:cytokine activity; IMP:UniProtKB.
DR   GO; GO:0005102; F:signaling receptor binding; IBA:GO_Central.
DR   GO; GO:0098586; P:cellular response to virus; NAS:ComplexPortal.
DR   GO; GO:0051607; P:defense response to virus; IMP:UniProtKB.
DR   GO; GO:0045087; P:innate immune response; IBA:GO_Central.
DR   GO; GO:0050778; P:positive regulation of immune response; IEA:InterPro.
DR   GO; GO:0038196; P:type III interferon-mediated signaling pathway; NAS:ComplexPortal.
DR   GO; GO:0007260; P:tyrosine phosphorylation of STAT protein; IDA:UniProtKB.
DR   FunFam; 1.20.1250.60:FF:000002; Interferon lambda-4; 1.
DR   Gene3D; 1.20.1250.60; Interferon lambda; 1.
DR   InterPro; IPR038326; IFN-lambda_sf.
DR   InterPro; IPR029177; INF_lambda.
DR   PANTHER; PTHR31943:SF17; INTERFERON LAMBDA-4; 1.
DR   PANTHER; PTHR31943; INTERLEUKIN-28 AND 29; 1.
DR   Pfam; PF15177; IL28A; 1.
DR   neXtProt; NX_K9M1U5; -.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Antiviral defense; Cytokine; Cytoplasm;
KW   Reference proteome; Secreted; Signal.
FT   SIGNAL          1..21
FT                   /evidence="ECO:0000255"
FT   CHAIN           22..179
FT                   /note="Interferon lambda-4"
FT                   /id="PRO_0000422094"
FT   REGION          130..149
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   VAR_SEQ         51..122
FT                   /note="Missing (in isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:23291588"
FT                   /id="VSP_046392"
FT   VAR_SEQ         75..122
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:23291588"
FT                   /id="VSP_046393"
FT   VAR_SEQ         123..179
FT                   /note="LELARPGSSRKVPGAQKRRHKPRRADSPRCRKASVVFNLLRLLTWELRLAAH
FT                   SGPCL -> VSDGRAPPPLSPASFSASSGPRRAPALCQSVLLSGKTHPDRSRVLWVS
FT                   (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:23291588"
FT                   /id="VSP_046394"
FT   CONFLICT        161
FT                   /note="L -> P (in Ref. 1; AFQ38550)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   179 AA;  19675 MW;  2010E94B6224D0F7 CRC64;
     MRPSVWAAVA AGLWVLCTVI AAAPRRCLLS HYRSLEPRTL AAAKALRDRY EEEALSWGQR
     NCSFRPRRDP PRPSSCARLR HVARGIADAQ AVLSGLHRSE LLPGAGPILE LLAAAGRDVA
     ACLELARPGS SRKVPGAQKR RHKPRRADSP RCRKASVVFN LLRLLTWELR LAAHSGPCL
//
